Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
3Y CAGR+88.7%
5Y CAGR-4.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+88.7%/yr
Annual compound
5Y CAGR
-4.0%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.10M | -52.3% |
| 2024 | $42.16M | +65.7% |
| 2023 | $25.44M | +750.0% |
| 2022 | $2.99M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $24.59M | +106.7% |
| 2019 | $11.90M | - |